Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene

D. S. Liscia, R. Morizio, T. Venesio, C. Palenzona, M. Donadio, R. Callahan

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Several studies indicate that the short arm of chromosome 17 is one of the most frequently altered regions in sporadic breast carcinomas (45-60%). In the present report the 17p13.3-ter locus in tumour DNA of breast cancer patients, along with their matching normal lymphocyte DNA, have been mapped with four markers (D17S5, D17S379, ABR and D17S34), spanning nearly 3 cM of the telomer. Sixty-five of 143 heterozygous tumours had lost at least one of the markers at the minimum region of loss (45%). High levels of loss of these distal markers on 17p13.3 are independent of TP53 mutations and are associated with tumour cell proliferation. A follow-up period of over 7 years demonstrates that loss of these markers correlates both with disease-free (P = 0.004) and overall survival (P = 0.007). In addition we show that for disease-free survival the prognostic power of this genetic alteration is second only to axillary lymph node involvement (3.1 vs 6.3 relative risk), and is a better predictor than the mutational status of TP53 (1.6 relative risk). Our results are further evidence of the presence, within the region, of at least a second tumour suppressor gene distal to TP53, that might be targeted by deletions.

Original languageEnglish
Pages (from-to)821-826
Number of pages6
JournalBritish Journal of Cancer
Volume80
Issue number5-6
DOIs
Publication statusPublished - 1999

Fingerprint

Loss of Heterozygosity
Tumor Suppressor Genes
Chromosomes
Breast Neoplasms
Neoplasms
Chromosomes, Human, Pair 17
DNA
Disease-Free Survival
Lymph Nodes
Cell Proliferation
Lymphocytes
Mutation
Survival

Keywords

  • Breast cancer
  • Chromosome 17p13.3
  • LOH
  • Survival

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene. / Liscia, D. S.; Morizio, R.; Venesio, T.; Palenzona, C.; Donadio, M.; Callahan, R.

In: British Journal of Cancer, Vol. 80, No. 5-6, 1999, p. 821-826.

Research output: Contribution to journalArticle

@article{4d06bc8ecc134a9da04b96acf92687d9,
title = "Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene",
abstract = "Several studies indicate that the short arm of chromosome 17 is one of the most frequently altered regions in sporadic breast carcinomas (45-60{\%}). In the present report the 17p13.3-ter locus in tumour DNA of breast cancer patients, along with their matching normal lymphocyte DNA, have been mapped with four markers (D17S5, D17S379, ABR and D17S34), spanning nearly 3 cM of the telomer. Sixty-five of 143 heterozygous tumours had lost at least one of the markers at the minimum region of loss (45{\%}). High levels of loss of these distal markers on 17p13.3 are independent of TP53 mutations and are associated with tumour cell proliferation. A follow-up period of over 7 years demonstrates that loss of these markers correlates both with disease-free (P = 0.004) and overall survival (P = 0.007). In addition we show that for disease-free survival the prognostic power of this genetic alteration is second only to axillary lymph node involvement (3.1 vs 6.3 relative risk), and is a better predictor than the mutational status of TP53 (1.6 relative risk). Our results are further evidence of the presence, within the region, of at least a second tumour suppressor gene distal to TP53, that might be targeted by deletions.",
keywords = "Breast cancer, Chromosome 17p13.3, LOH, Survival",
author = "Liscia, {D. S.} and R. Morizio and T. Venesio and C. Palenzona and M. Donadio and R. Callahan",
year = "1999",
doi = "10.1038/sj.bjc.6690427",
language = "English",
volume = "80",
pages = "821--826",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "5-6",

}

TY - JOUR

T1 - Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene

AU - Liscia, D. S.

AU - Morizio, R.

AU - Venesio, T.

AU - Palenzona, C.

AU - Donadio, M.

AU - Callahan, R.

PY - 1999

Y1 - 1999

N2 - Several studies indicate that the short arm of chromosome 17 is one of the most frequently altered regions in sporadic breast carcinomas (45-60%). In the present report the 17p13.3-ter locus in tumour DNA of breast cancer patients, along with their matching normal lymphocyte DNA, have been mapped with four markers (D17S5, D17S379, ABR and D17S34), spanning nearly 3 cM of the telomer. Sixty-five of 143 heterozygous tumours had lost at least one of the markers at the minimum region of loss (45%). High levels of loss of these distal markers on 17p13.3 are independent of TP53 mutations and are associated with tumour cell proliferation. A follow-up period of over 7 years demonstrates that loss of these markers correlates both with disease-free (P = 0.004) and overall survival (P = 0.007). In addition we show that for disease-free survival the prognostic power of this genetic alteration is second only to axillary lymph node involvement (3.1 vs 6.3 relative risk), and is a better predictor than the mutational status of TP53 (1.6 relative risk). Our results are further evidence of the presence, within the region, of at least a second tumour suppressor gene distal to TP53, that might be targeted by deletions.

AB - Several studies indicate that the short arm of chromosome 17 is one of the most frequently altered regions in sporadic breast carcinomas (45-60%). In the present report the 17p13.3-ter locus in tumour DNA of breast cancer patients, along with their matching normal lymphocyte DNA, have been mapped with four markers (D17S5, D17S379, ABR and D17S34), spanning nearly 3 cM of the telomer. Sixty-five of 143 heterozygous tumours had lost at least one of the markers at the minimum region of loss (45%). High levels of loss of these distal markers on 17p13.3 are independent of TP53 mutations and are associated with tumour cell proliferation. A follow-up period of over 7 years demonstrates that loss of these markers correlates both with disease-free (P = 0.004) and overall survival (P = 0.007). In addition we show that for disease-free survival the prognostic power of this genetic alteration is second only to axillary lymph node involvement (3.1 vs 6.3 relative risk), and is a better predictor than the mutational status of TP53 (1.6 relative risk). Our results are further evidence of the presence, within the region, of at least a second tumour suppressor gene distal to TP53, that might be targeted by deletions.

KW - Breast cancer

KW - Chromosome 17p13.3

KW - LOH

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=0032941268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032941268&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6690427

DO - 10.1038/sj.bjc.6690427

M3 - Article

C2 - 10360661

AN - SCOPUS:0032941268

VL - 80

SP - 821

EP - 826

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 5-6

ER -